Table 4.
US Cancer Death Rates for 2006-2010 and Fixed-Interval Trends From 2001 to 2010 for the Top Cancers by Sex, Race, and Ethnicitya
All Racial and Ethnic Groups Combined |
Whiteb |
Blackb |
APIb |
AI/AN (CHSDA Counties)b |
Hispanicb,c |
Non-Hispanicb,c |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex/Cancer Site or Typed |
Ra nk |
Ratee | 2001- 2010 AAP Cf |
2006- 2010 AAPCf |
Ran k |
Ratee | 2001- 2010 AAP Cf |
Ra nk |
Ratee | 2001- 2010 AAPC f |
Ra nk |
Ratee | 2001- 2010 AAP Cf |
Ran k |
Ratee | 2001- 2010 AAP Cf |
Ra nk |
Ratee | 2001- 2010 AAP Cf |
Ra nk |
Ratee | 200 1- 201 0 AA PCf |
All Sites | ||||||||||||||||||||||
Both Sexes | 176.4 | −1.5 g | −1.5 g | 175.8 | −1.4 g | 210.3 | −2.1 g | 108.8 | −1.2 g | 160.4 | −0.7 g | 121.9 | −1.4 g | 180.7 | −1.5 g | |||||||
Men | 215.3 | −1.8 g | −1.8 g | 213.1 | −1.7 g | 276.6 | −2.6 g | 132.4 | −1.3 g | 191.0 | −0.4 | 152.2 | −1.6 g | 219.9 | −1.7 g | |||||||
Women | 149.7 | −1.4 g | −1.4 g | 149.8 | −1.3 g | 171.2 | −1.7 g | 92.1 | −1.0 g | 139.0 | −1.1 g | 101.3 | −1.2 g | 153.7 | −1.3 g | |||||||
Children (ages 0-14) |
2.2 | −2.0 g | −2.0 g | 2.3 | −1.9 g | 2.1 | −2.3 g | 1.9 | −0.8 | 1.6 | h | 2.3 | −2.3 g | 2.2 | −2.0 g | |||||||
Children (ages 0-19) |
2.4 | −2.2 g | −2.2 g | 2.5 | −2.2 g | 2.3 | −2.3 g | 2.1 | −0.5 | 1.8 | −3.0 | 2.5 | −2.5 g | 2.4 | −2.2 g | |||||||
Top 17 cancers for mend |
||||||||||||||||||||||
Lung and Bronchus |
1 | 63.5 | −2.5 g | −2.8 g | 1 | 63.2 | −2.4 g | 1 | 78.5 | −3.3 g | 1 | 35.5 | −1.6 g | 1 | 49.6 | −0.5 | 1 | 31.3 | −2.8 g | 1 | 66.0 | −2.3 g |
Prostate | 2 | 23.0 | −3.4 g | −3.4 g | 2 | 21.2 | −3.3 g | 2 | 50.9 | −3.8 g | 4 | 10.1 | −2.3 g | 2 | 20.7 | −1.4 | 2 | 19.2 | −3.0 g | 2 | 23.2 | −3.3 g |
Colon and Rectum |
3 | 19.6 | −3.0 g | −3.0 g | 3 | 19.1 | −3.1 g | 3 | 28.7 | −2.4 g | 3 | 13.1 | −2.3 g | 3 | 18.7 | −1.5 | 3 | 16.1 | −1.4 g | 3 | 20.0 | −3.0 g |
Pancreas | 4 | 12.5 | 0.4 g | 0.4 g | 4 | 12.5 | 0.5 g | 4 | 15.3 | 0.0 | 6 | 8.3 | 0.5 | 5 | 10.1 | 5.7 | 5 | 9.6 | 0.5 | 4 | 12.8 | 0.5 g |
Leukemia | 5 | 9.5 | −1.0 g | −1.0 g | 5 | 9.8 | −0.9 g | 7 | 8.2 | −1.3 g | 8 | 5.0 | −0.2 | 8 | 7.0 | 3.7 g | 8 | 6.1 | −1.1 g | 5 | 9.7 | −0.9 g |
Liver and Intrahepatic Bile Duct |
6 | 8.3 | 2.5 g | 2.5 g | 9 | 7.6 | 2.6 g | 5 | 11.8 | 3.0 g | 2 | 14.4 | −0.5 | 4 | 13.2 | 3.3 | 4 | 12.3 | 1.9 g | 7 | 8.0 | 2.5 g |
Non- Hodgkin Lymphoma |
7 | 8.2 | −2.6 g | −2.6 g | 6 | 8.5 | −2.6 g | 10 | 5.9 | −2.0 g | 7 | 5.2 | −2.0 g | 10 | 5.4 | −1.8 | 7 | 6.5 | −1.4 g | 6 | 8.3 | −2.6 g |
Urinary Bladder |
8 | 7.7 | 0.1 | 0.1 | 7 | 8.1 | 0.2 | 12 | 5.5 | 0.0 | 12 | 2.8 | −1.0 | 11 | 4.1 | h | 11 | 4.0 | −1.1 | 8 | 8.0 | 0.3 g |
Esophagus | 9 | 7.6 | −0.5 g | −0.5 g | 8 | 7.8 | 0.1 | 9 | 7.7 | −4.6 g | 9 | 3.1 | −1.1 | 9 | 6.1 | −2.4 | 10 | 4.3 | −0.3 | 9 | 7.9 | −0.4 g |
Kidney and Renal Pelvis |
10 | 5.8 | −1.0 g | −1.0 g | 10 | 5.9 | −0.9 g | 11 | 5.7 | −1.3 g | 11 | 3.0 | 3.3 g | 6 | 9.5 | 0.1 | 9 | 5.1 | −1.5 | 10 | 5.8 | −0.9 g |
Brain and Other Nervous System |
11 | 5.2 | −0.5 | 0.5 | 11 | 5.6 | −0.4 | 15 | 3.0 | −0.8 | 13 | 2.3 | −1.5 | 14 | 2.8 | 1.0 | 13 | 3.3 | −0.1 | 11 | 5.4 | −0.5 |
Stomach | 12 | 4.9 | −3.2 g | −3.2 g | 13 | 4.2 | −3.4 g | 6 | 9.8 | −3.1 g | 5 | 8.7 | −3.1 g | 7 | 8.1 | −5.7 g | 6 | 7.6 | −2.9 g | 12 | 4.6 | −3.4 g |
Myeloma | 13 | 4.3 | −1.4 g | −1.4 g | 14 | 4.0 | −1.5 g | 8 | 7.9 | −1.3 g | 14 | 2.3 | 3.2 g | 12 | 3.6 | −3.6 g | 12 | 3.5 | −1.9 | 14 | 4.3 | −1.3 g |
Melanoma of the Skin |
14 | 4.1 | 0.9 g | 0.9 g | 12 | 4.6 | 1.0 g | 22 | 0.5 | 1.9 | 20 | 0.4 | h | 16 | 1.7 | h | 17 | 1.1 | 2.2 | 13 | 4.4 | 1.0 g |
Oral Cavity and Pharynx |
15 | 3.8 | −1.3 g | −1.3 g | 15 | 3.6 | −0.8 g | 13 | 5.2 | −3.7 g | 10 | 3.0 | −2.6 g | 13 | 3.4 | −3.4 | 14 | 2.5 | −1.9 g | 15 | 3.9 | −1.1 g |
Larynx | 16 | 2.0 | −2.7 g | −2.7 g | 16 | 1.9 | −2.4 g | 14 | 3.9 | −4.0 g | 16 | 0.8 | −2.6 | 15 | 2.1 | h | 15 | 1.7 | −2.7 g | 16 | 2.1 | −2.6 g |
Soft Tissue including Heart |
17 | 1.5 | 1.0 g | 1.0 g | 18 | 1.5 | 1.2 g | 16 | 1.4 | −0.8 | 15 | 0.9 | 1.2 | 17 | 1.3 | h | 16 | 1.1 | 1.4 | 18 | 1.5 | 1.0 g |
Top 18 cancers for womend |
||||||||||||||||||||||
Lung and Bronchus |
1 | 39.2 | −0.9 g | −1.5 g | 1 | 40.4 | −0.9 g | 1 | 37.2 | −1.0 g | 1 | 18.4 | −0.5 | 1 | 33.1 | −0.8 | 2 | 14.1 | −1.1 g | 1 | 41.3 | −0.8 g |
Breast | 2 | 22.6 | −2.0 g | −2.0 g | 2 | 22.1 | −2.0 g | 2 | 30.8 | −1.6 g | 2 | 11.5 | −1.7 g | 2 | 15.5 | 1.3 | 1 | 14.8 | −1.5 g | 2 | 23.3 | −1.8 g |
Colon and Rectum |
3 | 13.9 | −3.0 g | −3.0 g | 3 | 13.4 | −3.0 g | 3 | 19.0 | −3.3 g | 3 | 9.7 | −1.6 g | 3 | 15.4 | 0.4 | 3 | 10.2 | −2.1 g | 3 | 14.1 | −2.9 g |
Pancreas | 4 | 9.6 | 0.4 g | 0.4 g | 4 | 9.4 | 0.6 g | 4 | 12.5 | −0.4 | 4 | 7.1 | 0.5 | 4 | 8.6 | 0.5 | 4 | 7.8 | 0.1 | 4 | 9.7 | 0.5 g |
Ovary | 5 | 8.1 | −1.8 g | −1.8 g | 5 | 8.4 | −1.8 g | 6 | 6.7 | −1.2 | 7 | 4.8 | −0.6 | 5 | 7.1 | −2.3 | 5 | 5.8 | −1.2 g | 5 | 8.3 | −1.8 g |
Leukemia | 6 | 5.3 | −1.3 g | −1.0 g | 6 | 5.5 | −1.2 g | 8 | 4.8 | −1.9 g | 9 | 3.1 | 0.7 | 11 | 3.3 | −3.4 | 9 | 4.0 | −0.6 | 6 | 5.4 | −1.3 g |
Non- Hodgkin Lymphoma |
7 | 5.1 | −3.1 g | −2.8 g | 7 | 5.3 | −3.1 g | 12 | 3.6 | −3.0 g | 8 | 3.4 | −2.0 g | 8 | 4.3 | −3.8 | 7 | 4.4 | −1.5 g | 7 | 5.2 | −3.1 g |
Corpus and Uterus, NOS |
8 | 4.3 | 0.5 | 0.5 | 8 | 4.0 | 0.4 | 5 | 7.4 | 0.7 g | 10 | 2.6 | 2.3 g | 12 | 3.2 | h | 10 | 3.3 | 0.6 | 8 | 4.3 | 0.5 g |
Brain and Other Nervous System |
9 | 3.5 | −0.5 g | −0.5 g | 9 | 3.8 | −0.4 | 16 | 2.1 | −0.2 | 12 | 1.6 | 3.8 | 14 | 2.3 | h | 12 | 2.4 | −0.4 | 9 | 3.6 | −0.4 |
Liver and Intrahepatic Bile Duct |
10 | 3.4 | 2.0 g | 2.2 g | 10 | 3.2 | 1.9 g | 11 | 4.1 | 0.8 | 5 | 6.0 | −1.5 | 6 | 6.1 | −1.1 | 6 | 5.4 | 0.9 g | 10 | 3.2 | 1.6 g |
Myeloma | 11 | 2.7 | −2.3 g | −2.3 g | 12 | 2.5 | −2.3 g | 7 | 5.4 | −2.2 g | 13 | 1.3 | −2.5 | 13 | 2.4 | −6.2 | 13 | 2.3 | −2.3 g | 11 | 2.7 | −2.2 g |
Kidney and Renal Pelvis |
12 | 2.6 | −1.3 g | −1.3 g | 11 | 2.6 | −1.0 g | 14 | 2.6 | −1.1 g | 14 | 1.2 | −0.3 | 7 | 4.4 | −0.7 | 14 | 2.3 | −0.4 | 12 | 2.6 | −1.3 g |
Stomach | 13 | 2.5 | −2.7 g | −2.7 g | 14 | 2.2 | −2.7 g | 9 | 4.7 | −3.5 g | 6 | 5.1 | −3.7 g | 9 | 3.8 | −6.0 g | 8 | 4.4 | −2.6 g | 13 | 2.4 | −3.0 g |
Cervix Uteri | 14 | 2.4 | −1.8 g | −1.8 g | 15 | 2.2 | −1.3 g | 10 | 4.2 | −2.4 g | 11 | 1.9 | −4.6 g | 10 | 3.5 | −0.4 | 11 | 2.9 | −2.9 g | 14 | 2.3 | −1.8 g |
Urinary Bladder |
15 | 2.2 | −0.6 g | −0.6 g | 13 | 2.2 | −0.4 | 13 | 2.6 | −1.9 g | 16 | 0.9 | −1.1 | 18 | 1.2 | h | 16 | 1.3 | −1.9 | 15 | 2.3 | −0.5 |
Esophagus | 17 | 1.6 | −1.5 g | −1.5 g | 17 | 1.6 | −0.9 g | 15 | 2.1 | −5.2 g | 18 | 0.8 | 0.1 | 16 | 1.6 | h | 18 | 0.8 | −2.6 g | 17 | 1.7 | −1.4 g |
Oral Cavity and Pharynx |
18 | 1.4 | −1.5 g | −1.5 g | 18 | 1.4 | −1.3 g | 17 | 1.4 | −3.2 g | 15 | 1.2 | −2.4 | 17 | 1.5 | h | 19 | 0.8 | −1.6 | 18 | 1.4 | −1.4 g |
Gallbladder | 20 | 0.8 | −1.4 g | −1.4 g | 20 | 0.7 | −1.6 g | 19 | 1.0 | −0.8 | 20 | 0.8 | −0.3 | 15 | 2.0 | −5.2 | 15 | 1.3 | −1.6 | 20 | 0.7 | −1.5 g |
Abbreviations: AAPC, average annual percent change; API, Asian/Pacific Islander; AI/AN, American Indian/Alaska Native; CHSDA, Indian Health Service Contract Health Services Delivery Area; NOS, not otherwise specified.
Source: National Center for Health Statistics public-use data file for the total US, 1975-2010.
White, black, API, and AI/AN (CHSDA counties) populations include Hispanic and non-Hispanic; the race and ethnicity categories are not mutually exclusive.
Data for Hispanic and non-Hispanic exclude the District of Columbia, Minnesota, New Hampshire, North Dakota, and South Carolina.
Cancers are listed in descending rank order of sex-specific, age-adjusted incidence rates for 2006 to 2010 for all racial and ethnic groups combined. More than 15 cancers may appear under men and women to include the top 15 cancers in each racial and ethnic group.
Rates are per 100,000 persons and are age standardized to the 2000 US standard population (19 age groups: ages <1 year, 1-4 years, 5-9 years, …, 80-84 years, 85 years; Census publication p25-1130; US Bureau of the Census, Current Population Reports, p25-1130. Washington, DC: US Government Printing Office, 2000).
The AAPC is a weighted average of the annual percent change and is calculated by joinpoint analyses with up to 2 joinpoints yielding up to 3 trend segments based on rates per 100,000 persons and age standardized to the 2000 US standard population (19 age groups: ages <1 year, 1-4 years, 5-9 years, …, 80-84 years, 85 years; Census publication p25-1130). For joinpoint analysis, the Joinpoint Regression Program was used (version 4.0.3, April 2013; Surveillance Research Program, National Cancer Institute, Bethesda, Md).
The AAPC is statistically significantly different from zero (2-sided Z test; P <.05).
The statistic could not be calculated. The average annual percent change is based on <10 cases for at least 1 year within the time interval.